Scientific discovery has often followed a trajectory from small, isolated ideas to structured collaboration within established research institutions. Each year, at colleges and universities across the United States, over 1.4 million undergraduate students engage in some form of research experience, according to the National Center for Education Statistics. The purpose of these programs is to bridge the divide between theoretical coursework and the empirical work that drives scientific progress. Some universities have created remarkable undergraduate research initiatives. One example is the University of North Carolina at Chapel Hill, which aims to expose young scientists to an active lab environment that values data collection, reproducibility, and productive communication of results with colleagues.
The push for students to engage early in the research experience is consistent with a recognition, more broadly, that formal science education captures more than a technical capability; it also captures an engagement with active, ongoing research, access to and experience with expert methods, and the communal discipline of recording experiments in service of professional practice. Students studying subjects like molecular biology or genetics will join pre-existing research teams working on projects in protein function, gene regulation, or disease modeling. Most of the time, students are not working in isolation. They are part of an inquiry working toward some larger aim of the institution and, sometimes, the national interest, as supported by our government funding for science, for example, through the National Institutes of Health.
Within this context, Stephen Robert Litt’s development as a researcher at the University of North Carolina at Chapel Hill reflects the natural continuation of a scientific interest formed years earlier. Having initiated his academic journey as a student researcher into the possible anticancer effects of epigallocatechin gallate (EGCG), Litt came to UNC prepared for progression from individual inquiry to collaborative research. Early attention to cellular mechanisms gave him the conceptual background needed to understand the biochemical complexity he would face in structured laboratory work. The continuity between his school projects and his current academic setting shows that early exposure to scientific reasoning can underpin later engagement with advanced topics.
While at the University of North Carolina at Chapel Hill, Litt joined the Strahl Lab, a well-known lab conducting histone biology research and examining chromatin landscape regulation. The Strahl Lab, under the direction of Professor Brian D. Strahl, focuses on analyzing chemical modifications to histone proteins and determining how these modifications affect gene expression and genome stability. The biochemical modifications to histone proteins are termed epigenetic modifications because there is no change to the underlying DNA sequence; rather, these modifications influence how genetic information is read and ultimately expressed in any given cell. As well, epigenetic modifications play a role in developmental biology, and they are similarly important in aging and disease, especially in cancer, where errors in these pathways may contribute to uncontrolled cell growth.
Participation in a research group like the Strahl Lab marks a clear shift from individual experimentation to work that contributes to long-term scientific objectives. Here, training focuses on molecular and biochemical techniques standard across biomedical research methods, including protein extraction, immunoblotting, and cell culture maintenance. Laboratory work at UNC takes place in an environment of collective oversight and data validation. Experiments are replicated, results are peer-reviewed internally, and findings are weighed against broader questions about how chromatin structure shapes transcriptional activity.
The past two decades have marked a remarkable increase in histone research. Although the Human Genome Project provided a genetic blueprint, much of the information on how that genetic blueprint is regulated comes from our study of chromatin and histones. A 2022 report by the National Human Genome Research Institute estimates that nearly 70 percent of current research in molecular biology includes some form of epigenetic study. In this remarkable research context, labs, including Strahl’s, are working to define how histone modifications, specifically acetylation and methylation, could potentially influence gene regulation. As it relates to epigenetics, these histone modification studies are essential for understanding disease causation; for example, cancer progression may depend on sustained up- and down-regulation of chromatin states that regulate oncogenes and tumor suppressor genes.
Litt’s involvement in this kind of research marks a shift from basic model-organism research to the study of biochemical and genomic systems. The EGCG project that defined his early career explored how a naturally occurring chemical might affect tumor growth; his present surroundings introduce him to the molecular mechanisms underlying such effects. This, therefore, constitutes an academic deepening rather than a change in interest. Both undertakings revolve around the quest to understand cellular behavior, with the latter at a far higher degree of resolution, constrained as it is by established hypotheses and technical mentorship.
Scientific training in its evolution often mirrors the growth of individual researchers, moving from independent exploration to collaborative inquiry. In the case of Stephen Robert Litt, that evolution has followed a trajectory so consistent with the expectations of modern molecular biology. He is connected to chromatin and histone research through his work with the Strahl Lab, which is essential for understanding gene regulation and disease. The movement from single experiments to laboratory investigations marks one model of learning that respects both curiosity and methodological rigor. As participation in research among undergraduates at universities around the world grows, examples like Litt’s demonstrate how early involvement in scientific exchange and research can develop into work aligned with the broader objectives of biomedical research.
